<DOC>
	<DOCNO>NCT00881062</DOCNO>
	<brief_summary>This study determine ADME metabolite Proellex follow single oral dose 25 mg .</brief_summary>
	<brief_title>Investigate Absorption , Metabolism Excretion 14C } -Proellex Following Single Oral Dose Healthy Females</brief_title>
	<detailed_description>The purpose study determine absorption , metabolism , excretion kinetics Proellex determine characterize metabolite present plasma urine follow single oral dose 25 mg . The 25 mg dose select study include previous clinical trial . This dose well tolerate demonstrate efficacy uterine fibroid endometriosis .</detailed_description>
	<criteria>In good health , determine clinically significant finding medical history , 12lead ECG , vital sign Clinical laboratory evaluation within reference range test laboratory , unless deem clinically significant Investigator 1 2 bowel movement per day . Significant history significant clinical manifestation ( determined Investigator ) metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , neurological , psychiatric disorder History stomach intestinal surgery resection would potentially alter absorption and/or excretion orally administer drug Participation 1 radiolabeled investigational study drug trial within 12 month prior checkin Exposure significant radiation ( eg , serial xray compute tomography scan , barium meal , current employment job require radiation exposure monitoring ) within 12 month prior checkin Donation blood 30 day prior Screening Clinic Discharge , inclusive , plasma 2 week prior Screening clinic discharge , inclusive Receipt blood product within 2 month prior checkin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>ABSORPTION</keyword>
	<keyword>METABOLISM</keyword>
	<keyword>EXCRETION</keyword>
</DOC>